
Aditi Dutt
Examiner (ID: 15807, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1675 |
| Total Applications | 622 |
| Issued Applications | 221 |
| Pending Applications | 78 |
| Abandoned Applications | 328 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5666578
[patent_doc_number] => 20060171928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Monocyte-origin multipotent cell momc'
[patent_app_type] => utility
[patent_app_number] => 10/549707
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11886
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171928.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549707 | Monocyte-origin multipotent cell MOMC | Mar 17, 2004 | Issued |
Array
(
[id] => 4921949
[patent_doc_number] => 20080070264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Intracellular Signaling-Induced Ret-Independent Gdnf Receptor-Effected Morphological Changes'
[patent_app_type] => utility
[patent_app_number] => 10/548147
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15194
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548147
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548147 | Intracellular Signaling-Induced Ret-Independent Gdnf Receptor-Effected Morphological Changes | Mar 4, 2004 | Abandoned |
Array
(
[id] => 7677168
[patent_doc_number] => 20040152658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Immediate early genes and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 10/792481
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24625
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152658.pdf
[firstpage_image] =>[orig_patent_app_number] => 10792481
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/792481 | Immediate early genes and methods of use therefor | Mar 1, 2004 | Abandoned |
Array
(
[id] => 7276282
[patent_doc_number] => 20040235733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Methods and reagents for reducing polyglutamine toxicity'
[patent_app_type] => new
[patent_app_number] => 10/789518
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13679
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235733.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789518
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789518 | Methods and reagents for reducing polyglutamine toxicity | Feb 26, 2004 | Abandoned |
Array
(
[id] => 7313040
[patent_doc_number] => 20040143859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Novel proteins and methods for producing the proteins'
[patent_app_type] => new
[patent_app_number] => 10/785114
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21176
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785114 | Methods for using the osteoclastogenesis inhibitory factor (OCIF) protein | Feb 24, 2004 | Issued |
Array
(
[id] => 5872956
[patent_doc_number] => 20060165696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Remedy for spinal injury containing interleukin-6 antagonist'
[patent_app_type] => utility
[patent_app_number] => 10/546149
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12780
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165696.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546149
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546149 | Remedy for spinal injury containing interleukin-6 antagonist | Feb 23, 2004 | Abandoned |
Array
(
[id] => 5732288
[patent_doc_number] => 20060257405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr)'
[patent_app_type] => utility
[patent_app_number] => 10/545454
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32863
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257405.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545454 | Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr) | Feb 12, 2004 | Abandoned |
Array
(
[id] => 5734874
[patent_doc_number] => 20060259991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases'
[patent_app_type] => utility
[patent_app_number] => 10/543314
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14361
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20060259991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543314 | Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases | Feb 1, 2004 | Abandoned |
Array
(
[id] => 5844320
[patent_doc_number] => 20060122111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Regeneration and neogenesis of retinal visual cell otx2 gene'
[patent_app_type] => utility
[patent_app_number] => 10/542248
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15883
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542248
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542248 | Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein | Feb 1, 2004 | Issued |
Array
(
[id] => 7424485
[patent_doc_number] => 20040208862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Neuronal regeneration'
[patent_app_type] => new
[patent_app_number] => 10/754102
[patent_app_country] => US
[patent_app_date] => 2004-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 33401
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10754102
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/754102 | Neuronal regeneration | Jan 6, 2004 | Issued |
Array
(
[id] => 5209985
[patent_doc_number] => 20070248569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization'
[patent_app_type] => utility
[patent_app_number] => 10/541492
[patent_app_country] => US
[patent_app_date] => 2004-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9657
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20070248569.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541492 | Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization | Jan 5, 2004 | Abandoned |
Array
(
[id] => 7351206
[patent_doc_number] => 20040248795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Membrane-permeable peptide capable of calpain inhibition'
[patent_app_type] => new
[patent_app_number] => 10/751658
[patent_app_country] => US
[patent_app_date] => 2004-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3225
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10751658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/751658 | Membrane-permeable peptide capable of calpain inhibition | Jan 5, 2004 | Issued |
Array
(
[id] => 5674137
[patent_doc_number] => 20060179492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating'
[patent_app_type] => utility
[patent_app_number] => 10/538245
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12820
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20060179492.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538245
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538245 | Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating | Dec 7, 2003 | Abandoned |
Array
(
[id] => 5844318
[patent_doc_number] => 20060122110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 10/537757
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 46146
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537757 | Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system | Dec 4, 2003 | Abandoned |
Array
(
[id] => 5760664
[patent_doc_number] => 20060211609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Novel agent for improving neurotransmission failure'
[patent_app_type] => utility
[patent_app_number] => 10/536963
[patent_app_country] => US
[patent_app_date] => 2003-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5682
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211609.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536963
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536963 | Novel agent for improving neurotransmission failure | Nov 27, 2003 | Abandoned |
Array
(
[id] => 5912309
[patent_doc_number] => 20060127371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'ASB transcription repressor proteins and nucleic acids and their application in expansion of stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/536491
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18476
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127371.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536491
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536491 | ASB transcription repressor proteins and nucleic acids and their application in expansion of stem cells | Nov 24, 2003 | Abandoned |
Array
(
[id] => 7436763
[patent_doc_number] => 20040185113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein'
[patent_app_type] => new
[patent_app_number] => 10/478344
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4863
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185113.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478344 | Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein | Nov 20, 2003 | Abandoned |
Array
(
[id] => 7316702
[patent_doc_number] => 20040223966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'ActRIIB fusion polypeptides and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/689677
[patent_app_country] => US
[patent_app_date] => 2003-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14257
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20040223966.pdf
[firstpage_image] =>[orig_patent_app_number] => 10689677
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/689677 | ActRIIB fusion polypeptides and uses therefor | Oct 21, 2003 | Abandoned |
Array
(
[id] => 5630957
[patent_doc_number] => 20060147425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Use of enteric glia to promote functional nerve connections'
[patent_app_type] => utility
[patent_app_number] => 10/531425
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8173
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531425
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531425 | Use of enteric glia to promote functional nerve connections | Oct 14, 2003 | Abandoned |
Array
(
[id] => 7211558
[patent_doc_number] => 20050054012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Methods of detecting and treating facioscapulohumeral muscular dystrophy'
[patent_app_type] => utility
[patent_app_number] => 10/686491
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16902
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10686491
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/686491 | Methods of detecting and treating facioscapulohumeral muscular dystrophy | Oct 13, 2003 | Abandoned |